Epidarex Capital (Epidarex), an early-stage, transatlantic life science venture fund, has appointed Dr William R Sellers, William Burns and Dr. Frank M Armstrong to its advisory board.
Epidarex is a leading investor in high growth life science and health technologies in under-ventured markets. The advisory board provides strategic guidance and advice to Epidarex and its transatlantic portfolio of 14 early-stage life science companies.
Kyp Sirinakis, Managing Partner and co-founder of Epidarex, says: “As a leading, early-stage venture capital firm, Epidarex builds high-growth life science companies in under-ventured markets. We are delighted to welcome our new advisory board members and look forward to benefitting from their depth of scientific and commercial experience.”
